Back

Contemporary use of SGLT2i therapy among patients hospitalized for heart failure with reduced ejection fraction in the United States

20 May 2023 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: Chronic heart failure - pathophysiology and mechanisms 1 Heart Failure with Reduced Ejection Fraction (HFrEF) HFA Premium Access Heart Failure 2023 Heart Failure Association (HFA)

About the speaker

Photo
Professor Stephen Greene

Duke Clinical Research Institute, Durham (United States of America)

7 More presentations in this session

Presentation thumbnail
Right ventricular function and coupling to the pulmonary circulation in heart failure with preserved ejection fraction: the PARAGON-HF trial
Doctor R. Inciardi (Brescia, IT)
Abstract Slides
Presentation thumbnail
Achieved heart rate of less than 70 beats per minute after ivabradine treatment is related to left ventricular reverse remodeling in idiopathic dilated cardiomyopathy
Ms J. Lee (Seoul, KR)
Abstract Slides
Presentation thumbnail
Role of aldosterone in long-term left ventricular remodelling after acute myocardial infarction: the REMI study
Doctor L. Monzo (Vandoeuvre-Les-Nancy, FR)
Abstract Slides
Presentation thumbnail
Cardiac reverse remodeling in real life, a therapeuthic objective.
Miss C. Otte Alba (Sevilla, ES)
Abstract Slides
Presentation thumbnail
Effect of sacubitril/valsartan on cardiac remodeling compared with other renin-angiotensin-system inhibitors: a difference-in-difference analysis of propensity score matched samples
Doctor S. Sforna (Perugia, IT)
Abstract Slides

Access the full session

Session thumbnail
Chronic heart failure - pathophysiology and mechanisms 1

The Event

Event poster

Heart Failure 2023

20 May - 23 May 2023
You may be interested in
thumbnail
Congress Presentation
Distinguishing heart failure with reduced ejection fraction from heart failure with preserved ejection fraction: a phenomics approach.
thumbnail
Congress Presentation
Clinical characteristics and long-term prognosis of patients with heart failure with reduced, mildly reduced, and preserved left ventricular ejection fraction secondary to Chagas cardiomyopathy
thumbnail
Congress Session
Meet the Experts: summation of the science - treatment of chronic heart failure in 2023

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources